References
- Bouras EP, Lange SM, Scolapio JS. Rational approach to patients with unintentional weight loss. Mayo Clin Proc. 2001;76(9):923
- Beaton MD, Adams PC. Treatment of hyperferritinemia. Ann Hepatol. 2012;11(3):294–300
- Furić-Cunko V, Basić-Jukić N, Jurić I, Kes P. Hyperferritinemia in a kidney transplant recipient. Acta Clin Croat. 2011;50(2):245–248
- Fargion S, Valenti L, Fracanzani AL. Beyond hereditary hemochromatosis: new insights into the relationship between iron overload and chronic liver diseases. Dig Liver Dis. 2011;43(2):89–95
- Evans AT, Gupta R. Approach to the patient with weight loss. Available at: www.uptodate.com. Accessed October 21, 2012
- Hörl WH. Clinical aspects of iron use in the anemia of kidney disease. J Am Soc Nephrol. 2007;18(2):382–393
- Vaziri ND. Understanding iron: promoting its safe use in patients with chronic kidney failure treated by hemodialysis. Am J Kidney Dis. 2013;61(6):992–1000
- Mirahmadi KS, Paul WL, Winer RL, et al. Serum ferritin level determinant of iron requirement in hemodialysis patients. JAMA. 1977;238(7):601–603
- Bacon BR, Adams PC, Kowdley KV, Powell LW. Anthony S. Tavill. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology. 2011;54(1):328–343
- Niederau C, Strohmeyer G, Stremmel W. Epidemiology, clinical spectrum and prognosis of hemochromatosis. Adv Exp Med Biol. 1994;356:293--302
- Barton JC, McDonnell SM, Adams PC, et al. Management of hemochromatosis. Hemochromatosis Management Working Group. Ann Intern Med. 1998;129:932--939
- Wagner R, Tabák A, Bálint Z, Andrikovics H, Tordai A, Demeter J. A case of hemochromatosis diagnosed in a middle-aged patient with diabetes mellitus. Orv Hetil. 2006;147(25):1179–1184